Literature DB >> 23490548

Molecular mechanisms of cannabinoid addiction.

Walter Fratta1, Liana Fattore.   

Abstract

Cannabis is the world's most widely used illicit substance, with an estimated number of 119-224 million users worldwide. In recent years we assisted to an increased effort aimed to individuate the brain circuits underlying cannabis addiction and dependence. Similarly to other drugs of abuse, repeated exposure to cannabinoids causes brain neuroadaptations that persist long after drug effects, contribute to the negative affective states during withdrawal, and ultimately facilitate relapse. Recently, considerable progress has been made in understanding the cellular and molecular consequences of prolonged cannabis use, among which is the identification of specific set of transcriptional regulations that develop differently after chronic cannabinoids and in the abstinent brain.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23490548     DOI: 10.1016/j.conb.2013.02.002

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  15 in total

Review 1.  Cannabinoid abuse and addiction: Clinical and preclinical findings.

Authors:  L V Panlilio; S R Goldberg; Z Justinova
Journal:  Clin Pharmacol Ther       Date:  2015-05-02       Impact factor: 6.875

2.  Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids.

Authors:  Kenta Kuramoto; Nan Wang; Yuying Fan; Weiran Zhang; Frank J Schoenen; Kevin J Frankowski; Juan Marugan; Yifa Zhou; Sui Huang; Congcong He
Journal:  Autophagy       Date:  2016-06-15       Impact factor: 16.016

Review 3.  Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2019-01-03       Impact factor: 8.989

Review 4.  Is resting-state functional connectivity altered in regular cannabis users? A systematic review of the literature.

Authors:  Hannah Thomson; Izelle Labuschagne; Lisa-Marie Greenwood; Emily Robinson; Hannah Sehl; Chao Suo; Valentina Lorenzetti
Journal:  Psychopharmacology (Berl)       Date:  2021-08-20       Impact factor: 4.530

Review 5.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

Review 6.  The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis.

Authors:  M D Scofield; J A Heinsbroek; C D Gipson; Y M Kupchik; S Spencer; A C W Smith; D Roberts-Wolfe; P W Kalivas
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

7.  Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice.

Authors:  Hai-Ying Zhang; Hui Shen; Ming Gao; Zegang Ma; Briana J Hempel; Guo-Hua Bi; Eliot L Gardner; Jie Wu; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2021-03-28       Impact factor: 5.250

Review 8.  Keep off the grass? Cannabis, cognition and addiction.

Authors:  H Valerie Curran; Tom P Freeman; Claire Mokrysz; David A Lewis; Celia J A Morgan; Loren H Parsons
Journal:  Nat Rev Neurosci       Date:  2016-04-07       Impact factor: 38.755

Review 9.  Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies.

Authors:  Katia Befort
Journal:  Front Pharmacol       Date:  2015-02-05       Impact factor: 5.810

Review 10.  Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Authors:  Tonisha Kearney-Ramos; Margaret Haney
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-03-04       Impact factor: 5.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.